This is a Phase 1/2 trial registration with no reported results; the study was terminated before completion, precluding any evidence of efficacy or safety.
Reported
Planned enrollment45
Study phasePhase 1/2
Primary outcome measure 1Change of Serum Creatinine level at baselin…